Robust generation of cardiomyocytes from human iPS cells requires precise modulation of BMP and WNT signaling

Stem Cell Reviews and Reports

Volumn 11, Issue 4, 2015, Pages 560-569

  Kadari, Asifiqbal ^a,b   Mekala, Subbarao ^a   Wagner, Nicole ^a   Malan, Daniela ^a,b   Köth, Jessica ^c   Doll, Katharina ^b   Stappert, Laura ^b   Eckert, Daniela ^b   Peitz, Michael ^b   Matthes, Jan ^c   Sasse, Philipp ^a,b   Herzig, Stefan ^c   Brüstle, Oliver ^b   Ergün, Süleyman ^a   Edenhofer, Frank ^a,b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

BMP signaling; Cardiac differentiation; Diseasemodeling; Human iPS cells; Lactate enrichment; WNT signaling

Indexed keywords

CALCIUM; PROCOLLAGEN C PROTEINASE; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN; BONE MORPHOGENETIC PROTEIN;

ACTION POTENTIAL; ARTICLE; CALCIUM CURRENT; CELL DIFFERENTIATION; FLOW CYTOMETRY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; WHOLE CELL; WHOLE CELL PATCH CLAMP; CARDIAC MUSCLE CELL; CELL CULTURE TECHNIQUE; CELL LINE; CYTOLOGY; GENE EXPRESSION; INDUCED PLURIPOTENT STEM CELL; METABOLISM; PATCH CLAMP TECHNIQUE; PHYSIOLOGY; PROCEDURES; ULTRASTRUCTURE; WNT SIGNALING PATHWAY;

ACTION POTENTIALS; BONE MORPHOGENETIC PROTEINS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICROSCOPY, ELECTRON, TRANSMISSION; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; PLURIPOTENT STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; WNT SIGNALING PATHWAY;

EID: 84943273870     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-014-9564-6     Document Type: Article

References (43)

1. Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. (2006). Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet, 367, 1747–1757.
2. Orlic, D., Kajstura, J., Chimenti, S., et al. (2001). Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proceedings of the National Academy of Sciences of the United States of America, 98, 10344–10349.
3. Caplan, A. I., & Dennis, J. E. (2006). Mesenchymal stem cells as trophic mediators. Journal of Cellular Biochemistry, 98, 1076–1084.
4. Zaruba, M. M., Soonpaa, M., Reuter, S., & Field, L. J. (2010). Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts. Circulation, 121, 1992–2000.
5. Laugwitz, K. L., Moretti, A., Lam, J., et al. (2005). Postnatal ISL1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature, 433, 647–653.
6. Choi, S. H., Jung, S. Y., Kwon, S. M., & Baek, S. H. (2012). Perspectives on stem cell therapy for cardiac regeneration. Advances and challenges. Circulation Journal, 76, 1307–1312.
7. Cai, C. L., Liang, X., Shi, Y., et al. (2003). ISL1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Developmental Cell, 5, 877–889.
8. Hou, J., Wang, L., Jiang, J., et al. (2013). Cardiac stem cells and their roles in myocardial infarction. Stem Cell Reviews, 9, 326–338.
9. Murry, C. E., & Keller, G. (2008). Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell, 132, 661–680.
10. Laflamme, M. A., & Murry, C. E. (2011). Heart regeneration. Nature, 473, 326–335.
11. Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663–676.
12. Passier, R., Oostwaard, D. W., Snapper, J., et al. (2005). Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cells, 23, 772–780.
13. Kehat, I., Kenyagin-Karsenti, D., Snir, M., et al. (2001). Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. The Journal of Clinical Investigation, 108, 407–414.
14. Takei, S., Ichikawa, H., Johkura, K., et al. (2009). Bone morphogenetic protein-4 promotes induction of cardiomyocytes from human embryonic stem cells in serum-based embryoid body development. American Journal of Physiology. Heart and Circulatory Physiology, 296, H1793–H1803.
15. Mummery, C. L., Zhang, J., Ng, E. S., Elliott, D. A., Elefanty, A. G., & Kamp, T. J. (2012). Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circulation Research, 111, 344–358.
16. Osafune, K., Caron, L., Borowiak, M., et al. (2008). Marked differences in differentiation propensity among human embryonic stem cell lines. Nature Biotechnology, 26, 313–315.
17. Kaichi, S., Hasegawa, K., Takaya, T., et al. (2010). Cell linedependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice. Cardiovascular Research, 88, 314–323.
18. Ohno, Y., Yuasa, S., Egashira, T., et al. (2013). Distinct iPS Cells Show Different Cardiac Differentiation Efficiency. Stem Cells International, 2013, 659739.
19. Laflamme, M. A., Chen, K. Y., Naumova, A. V., et al. (2007). Cardiomyocytes derived from human embryonic stem cells in prosurvival factors enhance function of infarcted rat hearts. Nature Biotechnology, 25, 1015–1024.
20. Zhang, Q., Jiang, J., Han, P., et al. (2011). Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals. Cell Research, 21, 579–587.
21. Uosaki, H., Fukushima, H., Takeuchi, A., et al. (2011). Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression. PLoS One, 6, e23657.
22. Kattman, S. J., Witty, A. D., Gagliardi, M., et al. (2011). Stagespecific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell, 8, 228–240.
23. Sa, S., & McCloskey, K. E. (2012). Stage-specific cardiomyocyte differentiation method for H7 and H9 human embryonic stem cells. Stem Cell Reviews, 8, 1120–1128.
24. Burridge, P. W., Keller, G., Gold, J. D., & Wu, J. C. (2012). Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell, 10, 16–28.
25. Marvin, M. J., Di Rocco, G., Gardiner, A., Bush, S.M., & Lassar, A. B. (2001). Inhibition of Wnt activity induces heart formation from posterior mesoderm. Genes and Development, 15, 316–327.
26. Ueno, S., Weidinger, G., Osugi, T., et al. (2007). Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 104, 9685–9690.
27. Ren, Y., Lee, M. Y., Schliffke, S., et al. (2011). Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells. Journal of Molecular and Cellular Cardiology, 51, 280–287.
28. Lian, X., Hsiao, C., Wilson, G., et al. (2012). Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proceedings of the National Academy of Sciences of the United States of America, 109, E1848–E1857.
29. Minami, I., Yamada, K., Otsuji, T. G., et al. (2012). A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine- and xeno-free conditions. Cell Reports, 2, 1448–1460.
30. Cao, N., Liu, Z., Chen, Z., et al. (2011). Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells. Cell Research, 22, 219–236.
31. Cao, N., Liang, H., Huang, J., et al. (2013). Highly efficient induction and long-term maintenance ofmultipotent cardiovascular progenitors from human pluripotent stem cells under defined conditions. Cell Research, 23, 1119–1132.
32. Tohyama, S., Hattori, F., Sano, M., et al. (2013). Distinct metabolic flow enables large-scale purification ofmouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell, 12, 127–137.
33. Kadari, A., Lu, M., Li, M., et al. (2014). Excision of viral reprogramming cassettes by Cre protein transduction enables rapid, robust and efficient derivation of transgene-free human induced pluripotent stem cells. Stem Cell Research & Therapy, 5, 47.
34. Linta, L., Stockmann, M., Kleinhans, K. N., et al. (2012). Rat embryonic fibroblasts improve reprogramming of human keratinocytes into induced pluripotent stem cells. Stem Cells and Development, 21, 965–976.
35. Koch, P., Breuer, P., Peitz, M., et al. (2011). Excitation-induced ataxin-3 aggregation in neurons from patients with Machado- Joseph disease. Nature, 480, 543–546.
36. Fuerer, C., & Nusse, R. (2010). Lentiviral vectors to probe and manipulate the Wnt signaling pathway. PloS One, 5, e9370.
37. Yang, L., Soonpaa, M. H., Adler, E. D., et al. (2008). Human cardiovascular progenitor cells develop from a KDR+embryonicstem- cell-derived population. Nature, 453, 524–528.
38. Malan, D., Friedrichs, S., Fleischmann, B. K., & Sasse, P. (2011). Cardiomyocytes obtained from induced pluripotent stem cells with long-QT syndrome 3 recapitulate typical disease-specific features in vitro. Circulation Research, 109, 841–847.
39. Lian, X., Zhang, J., Zhu, K., Kamp, T. J., & Palecek, S. P. (2013). Insulin inhibits cardiac mesoderm, not mesendoderm, formation during cardiac differentiation of human pluripotent stem cells and modulation of canonical Wnt signaling can rescue this inhibition. Stem Cells, 31, 447–457.
40. Beetz, N., Hein, L., Meszaros, J., et al. (2009). Transgenic simulation of human heart failure-like L-type Ca2+-channels: implications for fibrosis and heart rate in mice. Cardiovascular Research, 84, 396–406.
41. Jangsangthong, W., Kuzmenkina, E., Khan, I. F., Matthes, J., Hullin, R., & Herzig, S. (2010). Inactivation of L-type calcium channels is determined by the length of the N terminus of mutant beta(1) subunits. Pflügers Archiv, 459, 399–411.
42. Carpenter, L., Carr, C., Yang, C. T., Stuckey, D. J., Clarke, K., & Watt, S. M. (2011). Efficient differentiation of human induced pluripotent stem cells generates cardiac cells that provide protection following myocardial infarction in the rat. Stem Cells and Development, 21, 977–986.
43. Dambrot, C., Buermans, HP., Varga, E., et al. (2014). Strategies for rapidly mapping proviral integration sites and assessing cardiogenic potential of nascent human induced pluripotent stem cell clones. Exp Cell Res.